title: Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia.
abstract: Increased numbers of T regulatory (T(reg)) cells are found in B-chronic lymphocytic leukemia, but the nature and function of these T(regs) remains unclear. Detailed characterization of the T(regs) in chronic lymphocytic leukemia has not been performed and the degree of heterogeneity of among these cells has not been studied to date. Using 15-color flow cytometry we show that T(reg) cells, defined using CD4, CD25, and forkhead box P3 (FOXP3), can be divided into multiple complex subsets based on markers used for naïve, memory, and effector delineation as well as markers of T(reg) activation. Furthermore FOXP3(+) cells can be identified among CD4(+)CD25(-) as well as CD8(+)CD4(-) populations in increased proportions in patients with chronic lymphocytic leukemia compared with healthy donors. Significantly different frequencies of naïve and effector T(regs) populations are found in healthy donor controls compared with donors with chronic lymphocytic leukemia. A population of CCR7(+)CD39(+) T(regs) was significantly associated with chronic lymphocytic leukemia. This population demonstrated slightly reduced suppressive activity compared with total T(regs) or T(regs) of healthy donors. These data suggest that FOXP3-expressing cells, particularly in patients with chronic lymphocytic leukemia are much more complex for T(reg) sub-populations and transitions than previously reported. These findings demonstrate the complexity of regulation of T-cell responses in chronic lymphocytic leukemia and illustrate the use of high-dimensional analysis of cellular phenotypes in facilitating understanding of the intricacies of cellular immune responses and their dysregulation in cancer.
authors.affiliation: Center for Human Immunology, Autoimmunity and Inflammation, National Heart Lung and Blood Institute, Bethesda, MD, USA.
authors.forename: Angélique
authors.initials: A
authors.lastname: Biancotto
authors.forename: Pradeep K
authors.initials: PK
authors.lastname: Dagur
authors.forename: John C
authors.initials: JC
authors.lastname: Fuchs
authors.forename: Adrian
authors.initials: A
authors.lastname: Wiestner
authors.forename: C Bruce
authors.initials: CB
authors.lastname: Bagwell
authors.forename: J Philip
authors.initials: JP
authors.lastname: McCoy
mesh_terms: D000328:Adult; D002469:Cell Separation; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000473:pathology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000473:pathology
references.citation: Blood. 2005 Sep 15;106(6):2018-25
references.pmid: 15914560
references.citation: Blood. 2003 Aug 1;102(3):1057-63
references.pmid: 12689926
references.citation: J Immunol Methods. 2007 Apr 30;322(1-2):1-11
references.pmid: 17368474
references.citation: Cytometry A. 2008 Nov;73(11):975-83
references.pmid: 18785267
references.citation: J Immunol. 2010 Apr 15;184(8):4317-26
references.pmid: 20231690
references.citation: Nat Med. 2004 Sep;10(9):942-9
references.pmid: 15322536
references.citation: Trends Immunol. 2006 Dec;27(12):541-4
references.pmid: 17045841
references.citation: Blood. 2006 Apr 1;107(7):2830-8
references.pmid: 16332974
references.citation: Leuk Lymphoma. 2009 May;50(5):788-801
references.pmid: 19452318
references.citation: J Exp Med. 2006 Jul 10;203(7):1701-11
references.pmid: 16818678
references.citation: Blood. 1999 Sep 15;94(6):1848-54
references.pmid: 10477713
references.citation: Immunity. 2006 Aug;25(2):195-201
references.pmid: 16920638
references.citation: Leuk Lymphoma. 2009 May;50(5):687-8
references.pmid: 19452314
references.citation: Nat Immunol. 2009 Jul;10(7):689-95
references.pmid: 19536194
references.citation: Leukemia. 2008 Jan;22(1):222-4
references.pmid: 17657216
references.citation: Blood. 1999 Sep 15;94(6):1840-7
references.pmid: 10477712
references.citation: Curr Protoc Cytom. 2001 May;Chapter 10:Unit 10.7
references.pmid: 18770681
references.citation: Cytokine Growth Factor Rev. 1999 Mar;10(1):41-60
references.pmid: 10379911
references.citation: J Exp Med. 1998 Jul 20;188(2):287-96
references.pmid: 9670041
references.citation: Ann Oncol. 2006 Apr;17(4):683-90
references.pmid: 16524977
references.citation: Immunology. 2005 Aug;115(4):516-25
references.pmid: 16011520
references.citation: Eur J Immunol. 2001 Apr;31(4):1122-31
references.pmid: 11298337
references.citation: Gut. 2009 Apr;58(4):520-9
references.pmid: 19022917
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4091-6
references.pmid: 15753306
references.citation: Leuk Lymphoma. 2003 Mar;44(3):383-9
references.pmid: 12688308
references.citation: J Clin Invest. 2005 Jul;115(7):1953-62
references.pmid: 16007258
references.citation: J Immunol. 2001 Mar 1;166(5):3008-18
references.pmid: 11207250
references.citation: J Immunol. 2009 Feb 15;182(4):2124-30
references.pmid: 19201865
references.citation: Blood. 1994 Apr 15;83(8):2198-205
references.pmid: 7909242
references.citation: J Immunol. 2002 Dec 1;169(11):6210-7
references.pmid: 12444126
references.citation: J Immunol. 2000 Jan 1;164(1):183-90
references.pmid: 10605010
references.citation: Clin Adv Hematol Oncol. 2007 Apr;5(4):257-61
references.pmid: 17607284
references.citation: J Leukoc Biol. 2008 Dec;84(6):1454-61
references.pmid: 18780874
references.citation: Am J Hematol. 1998 Feb;57(2):93-100
references.pmid: 9462539
references.citation: Cytokines Cell Mol Ther. 1999 Mar;5(1):25-39
references.pmid: 10390077
references.citation: Ann N Y Acad Sci. 2008 Nov;1143:151-69
references.pmid: 19076349
references.citation: Leukemia. 2005 May;19(5):750-8
references.pmid: 15759031
references.citation: Leuk Res. 2011 Mar;35(3):363-8
references.pmid: 20880586
references.citation: Oncol Rep. 2008 Sep;20(3):677-82
references.pmid: 18695923
references.citation: J Immunol Methods. 2009 Jul 31;346(1-2):55-63
references.pmid: 19450601
references.citation: Novartis Found Symp. 2003;252:67-88; discussion 88-91, 106-14
references.pmid: 14609213
references.citation: J Immunol. 2011 Aug 15;187(4):1684-91
references.pmid: 21746966
references.citation: Proc Natl Acad Sci U S A. 2005 May 31;102(22):7916-21
references.pmid: 15905333
references.citation: Clin Immunol. 2009 Mar;130(3):298-303
references.pmid: 19008157
references.citation: Nat Rev Immunol. 2009 Sep;9(9):662-8
references.pmid: 19680250
references.citation: Mech Ageing Dev. 2009 Aug;130(8):509-17
references.pmid: 19540259
references.citation: Folia Histochem Cytobiol. 2008;46(2):147-52
references.pmid: 18519230
references.citation: Methods Mol Biol. 2011;699:31-51
references.pmid: 21116977